Todays Report: Today, Raymond James Trust N.A. Reached $547,000 position of Amsurg Corp. (AMSG)

Today, Raymond James Trust N.A. Reached $547,000 position  of Amsurg Corp. (AMSG)

Raymond James Trust N.A. boosted its stake in shares of Amsurg Corp. (NASDAQ:AMSG) by 61.6% during the third quarter, Holdings Channel reports. The firm owned 8,148 shares of the company’s stock after buying an additional 3,106 shares during the period. Raymond James Trust N.A.’s holdings in Amsurg Corp. were worth $547,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of the stock. Calvert Investment Management Inc. raised its position in shares of Amsurg Corp. by 0.9% in the second quarter. Calvert Investment Management Inc. now owns 3,180 shares of the company’s stock valued at $247,000 after buying an additional 29 shares in the last quarter. Howe & Rusling Inc. raised its position in shares of Amsurg Corp. by 0.8% in the second quarter. Howe & Rusling Inc. now owns 8,695 shares of the company’s stock valued at $674,000 after buying an additional 65 shares in the last quarter. Northwestern Mutual Investment Management Company LLC raised its position in shares of Amsurg Corp. by 1.0% in the second quarter. Northwestern Mutual Investment Management Company LLC now owns 9,334 shares of the company’s stock valued at $724,000 after buying an additional 93 shares in the last quarter. GHP Investment Advisors Inc. raised its position in shares of Amsurg Corp. by 1.0% in the second quarter. GHP Investment Advisors Inc. now owns 15,875 shares of the company’s stock valued at $1,231,000 after buying an additional 155 shares in the last quarter. Finally, Cardinal Capital Management raised its position in shares of Amsurg Corp. by 3.7% in the second quarter. Cardinal Capital Management now owns 7,051 shares of the company’s stock valued at $547,000 after buying an additional 251 shares in the last quarter. 98.67% of the stock is owned by institutional investors and hedge funds.

Shares of Amsurg Corp. (NASDAQ:AMSG) traded up 0.71% during midday trading on Friday, hitting $66.22. 296,468 shares of the company’s stock were exchanged. The stock’s 50 day moving average is $64.34 and its 200-day moving average is $70.20. The stock has a market cap of $3.56 billion, a PE ratio of 20.44 and a beta of 0.67. Amsurg Corp. has a 1-year low of $57.32 and a 1-year high of $86.17.

Amsurg Corp. (NASDAQ:AMSG) last issued its quarterly earnings results on Tuesday, November 1st. The company reported $1.13 EPS for the quarter, hitting analysts’ consensus estimates of $1.13. The business earned $822.20 million during the quarter, compared to the consensus estimate of $770.29 million. Amsurg Corp. had a net margin of 6.06% and a return on equity of 8.05%. The company’s quarterly revenue was up 26.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.03 earnings per share. Analysts predict that Amsurg Corp. will post $4.31 earnings per share for the current fiscal year.

Several equities analysts have recently commented on AMSG shares. Citigroup Inc. started coverage on shares of Amsurg Corp. in a report on Monday, September 26th. They issued a “buy” rating and a $79.00 price objective on the stock. Mizuho lowered shares of Amsurg Corp. from a “buy” rating to a “neutral” rating and decreased their price objective for the stock from $95.00 to $71.00 in a report on Wednesday, November 9th. Wells Fargo & Co. upgraded shares of Amsurg Corp. from a “market perform” rating to an “outperform” rating in a report on Wednesday, November 2nd. They noted that the move was a valuation call. KeyCorp restated a “positive” rating and issued a $87.00 price objective on shares of Amsurg Corp. in a report on Tuesday, October 4th. Finally, Zacks Investment Research lowered shares of Amsurg Corp. from a “buy” rating to a “hold” rating in a report on Friday, August 5th. Three analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $89.45.

Amsurg Corp. Company Profile

AmSurg Corp. is a surgical center and physician services company. The Company is an owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology.

Related posts

Leave a Comment